Palantir Technologies' (NASDAQ: PLTR) rally is showing no signs of slowing down despite the company's sky-high valuation. As of this writing, the stock has jumped an impressive 87% year to date ...

The hot artificial intelligence (AI) market has birthed a number of high-flying AI stocks. The company's share price soared more than 200% over the past 12 months through June 18. The stock hit a ...

Genentech (DNA) Stock Chart The pivot points are available 24/7 to our members. Please register or login, goto the My Stocks Tab, add your stocks, and you'll get all the plans for all the stocks on ...

United States stock market 2025 holiday schedule Markets will be closed for the following holidays: Juneteenth: Thursday, June 19 Independence Day: Friday, July 4 Labor Day: Monday, Sept. 1 ...

Nintendo (OTC: NTDOY) stock saw another day of big gains in Wednesday's trading. Nintendo's gains today were driven by indications that demand for its recently released Switch 2 gaming console ...

That helped the stock rally nearly 30% today to close at $5.59. This all comes in the wake of President Trump’s executive order on deep sea mining back on April 24 th.

Escalating conflict between Israel and Iran sent the stock market falling on Friday. The Dow Jones Industrial Average dropped 770 points, or 1.8%. The S&P 500 fell 1.1%. The Nasdaq Composite was ...

Dow Jones is up 0.03% to 42,879.84. Nasdaq is up 0.16% to 19,646.39. S&P 500 is up 0.19% to 6,033.64. Advisory Alert: It has come to our attention that certain individuals are representing ...

Continental Airlines (CAL) Stock Chart The pivot points are available 24/7 to our members. Please register or login, goto the My Stocks Tab, add your stocks, and you'll get all the plans for all the ...

That raised expectations for the Federal Reserve to begin cutting interest rates later this year. Oracle helped lift the stock market following its better-than-expected profit report and forecast for ...

German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it said on Thursday, to boost its work on new mRNA-based cancer treatments.